Home

David Hirsch

CIK 1619884 · last filed 2024-05-28

David Hirsch is a corporate insider who has filed 34 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for RPID, was dated May 28, 2024. Across all open-market trades the lifetime net is +$7.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.09M

Companies

6

Total Filings

34

Lifetime Open-Market Net

$7.82M

Filer Profile

Reported Address
C/O LONGITUDE CAPITAL PARTNERS, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK, CA 94025
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPID Director 3,422,252 $1.23 $4.21M $0 5 2024-05-28
Tricida, Inc. (TCDA) Delisted Director 3,047,318 $0.11 $329.1K $2.50M 5 2022-06-16
Molecular Templates, Inc. (MTEM) Delisted Director 213,379 $0.00 $21 $17.00M 10 2022-06-06
Poseida Therapeutics, Inc. (PSTX) Delisted Director 2,714,245 $9.50 $25.79M $4.00M 4 2021-07-26
COLL Director 82,504 $22.75 $1.88M $1.92M 4 2020-05-22
COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted Director 57,325 $3.18 $182.3K -$17.60M 6 2019-09-03

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-05-28 RPID Grant (A) +14,300 $0 EDGAR
2023-05-05 RPID Grant (A) — $0 EDGAR
2022-06-16 Tricida, Inc. (TCDA) Delisted Grant (A) — $0 EDGAR
2022-06-10 RPID Grant (A) — $0 EDGAR
2022-06-06 Molecular Templates, Inc. (MTEM) Delisted Grant (A) — $0 EDGAR
2021-07-26 Poseida Therapeutics, Inc. (PSTX) Delisted Grant (A) — $0 EDGAR
2021-07-20 RPID Conv (C) +3,344,038 $0 EDGAR
2021-07-15 RPID Grant (A) — $0 EDGAR
2021-06-17 Poseida Therapeutics, Inc. (PSTX) Delisted Grant (A) — $0 EDGAR
2021-06-11 Tricida, Inc. (TCDA) Delisted Grant (A) +16,403 $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.